Answers are grounded in this paper and cite their sources.
Investigates miR-431-5p effects on asthma in children, suggesting diagnostic potential for biomarkers.
OBJECTIVE: This study investigated the clinical significance of miR-431-5p in childhood asthma and its cell function in house dust mite (HDM)-induced cell models. METHODS: Differential miRNA expression was analyzed in the GSE263408 dataset using bioinformatics tools (Limma package). Serum levels of miR-431-5p and CD34 mRNA in asthmatic and healthy children were measured. The diagnostic and prognostic potentials of miR-431-5p were evaluated using ROC curve analysis. The targeting relationship between miR-431-5p and CD34 was predicted by TargetScan and validated by dual-luciferase reporter assay. In vitro, transfected with miR-431-5p mimic or CD34 pcDNA, human airway smooth muscle cells (ASMCs) and mast cells were treated with HDM to assess effects on RNA expression, ASMC cell viability, and mast cell degranulation/histamine content. RESULTS: Bioinformatic analysis identified miR-431-5p as differentially expressed in asthma. Serum miR-431-5p was significantly downregulated in asthmatic children compared to healthy controls, showing diagnostic value (AUC = 0.866). It was further decreased in children with asthma recurrence/exacerbation, with an AUC of 0.787 in discriminating recurrence/exacerbation from none. miR-431-5p targeted CD34 3'UTR. In HDM-induced ASMCs, miR-431-5p mimic reduced CD34, MUC5AC mRNA, and cell viability, which were rescued by CD34 overexpression. In HDM-induced mast cells, miR-431-5p mimic reduced CD34 mRNA, degranulation, and histamine content, effects also reversed by CD34 overexpression. CONCLUSIONS: Serum miR-431-5p had potentials as a biomarker for childhood asthma. miR-431-5p may mitigate asthma-related cellular processes by targeting CD34.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: